Doctor profile · Federal record
Dr. SONIA ALI, M.D.
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Hematology (Internal Medicine) Physician · Medical Oncology Physician · LA JOLLA, CA
- NPI 1730451089
- Accepts Medicare
- 16 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
10710 N TORREY PINES RD
LA JOLLA, CA 920371035
(858) 554-8788
fax (858) 554-8946 - Additional location
-
15004 Innovation Dr
San Diego, CA 921283491
(858) 605-7146
fax (858) 605-7175 - Mailing address
-
10790 RANCHO BERNARDO RD
SAN DIEGO, CA 921275705
Credentials & registration
- NPI registered
- February 2012 — 14 yrs on file
- Profile last updated
- March 16, 2021
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A123537
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1730451089. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
39,096
Distinct HCPCS
10
Medicare allowed
$869,988
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9267 |
Injection, paclitaxel, 1 mg | 9,054 | 12 | $0 | |
J0185 |
Injection, aprepitant, 1 mg | 8,710 | 23 | $2 | |
J0897 |
Injection, denosumab, 1 mg | 6,542 | 51 | $23 | |
J9271 |
Injection, pembrolizumab, 1 mg | 5,000 | 12 | $55 | |
Q5116 |
Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg | 1,974 | 12 | $22 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,500 | 41 | $0 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 1,410 | 52 | $0 | |
J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 870 | 11 | $48 | |
J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 576 | 16 | $102 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 562 | 353 | $137 |
In context: peer comparison
Among 16 peers in this city , average services per provider: 1,484. This provider delivers 26× the peer median.Open Payments
Industry payments received
All-time total
$980
Transactions
33
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 8 | $170.71 | |
| BeiGene USA, Inc. | 3 | $80.62 | |
| ABBVIE INC. | 3 | $79.67 | |
| SpringWorks Therapeutics, Inc. | 3 | $76.83 | |
| PharmaEssentia USA Corporation | 2 | $65.01 | |
| SOBI, INC | 2 | $55.28 | |
| AstraZeneca Pharmaceuticals LP | 2 | $54.78 | |
| Merck Sharp & Dohme LLC | 3 | $52.62 | |
| Astellas Pharma US Inc | 1 | $34.65 | |
| Coherus Biosciences Inc. | 1 | $31.16 | |
| Celgene Corporation | 1 | $28.95 | |
| TAIHO ONCOLOGY, INC. | 1 | $28.82 | |
| Novartis Pharmaceuticals Corporation | 1 | $28.80 | |
| Deciphera Pharmaceuticals Inc. | 1 | $27.39 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $22.58 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,777
Patients
584
Total drug cost
$1,136,408
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 1,112 | 353 | $40,373 |
| Tamoxifen Citrate | Generic | 167 | 54 | $7,849 |
| Exemestane | Generic | 105 | 35 | $26,310 |
| Letrozole | Generic | 64 | 24 | $2,606 |
| Gabapentin | Generic | 43 | 18 | $789 |
| Dexamethasone | Generic | 40 | 22 | $822 |
| Lorazepam | Generic | 35 | 0 | $210 |
| Ibrance (Palbociclib) | Brand | 33 | 0 | $525,085 |
| Prochlorperazine Maleate | Generic | 31 | 25 | $862 |
| Eliquis (Apixaban) | Brand | 30 | 0 | $21,488 |